drugset / Trial / NCT00938626

Treated T Cells Followed by a Stem Cell Transplant in Treating Patients With Multiple Myeloma

NCT00938626 ↗

NaSingle-groupOpen-labelTreatment

Summary

RATIONALE: Giving chemotherapy followed by treated T cells before a stem cell transplant stops the growth of cancer cells by stopping them from dividing or by killing them. After treatment, stem cells are collected from the patient's blood and stored. High-dose chemotherapy is given to prepare the bone marrow for the stem cell transplant. The stem cells are then returned to the patient to replace the blood-forming cells that were destroyed by the chemotherapy. PURPOSE: This phase I trial is studying the side effects and best way to give treated T cells followed by stem cell transplant in treating patients with multiple myeloma.

Timeline

Start
2009-10
Primary completion
2011-10
Completion
2013-03

Drugs

EvaluationDrugModalityDoseRoute
Subject anti-CD3 x anti-CD20 bispecific antibody-armed activated T cells Unknown — Intravenous

Indications